RecruitingPhase 2NCT06705387
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
Studying NON RARE IN EUROPE: Eosinophilic esophagitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Colorado, Denver
- Intervention
- Dupilumab(biological)
- Enrollment
- 72 enrolled
- Eligibility
- 12-25 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Children's Hospital Colorado/University of Colorado School of Medicine, Aurora, Colorado, United States
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06705387 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Eosinophilic esophagitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07112378A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisRegeneron Pharmaceuticals
- RECRUITINGNCT07156357Surface EMG Testing on Swallowing in EoE PatientsMayo Clinic
- RECRUITINGNCT06972147Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic EsophagitisUniversity Hospital, Angers
- RECRUITINGNCT07012928Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II InflammationAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGPHASE2NCT05485155Zemaira Eosinophilic Esophagitis Pilot StudyChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06756581Tolerability of Baked Dairy Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein TriggerShaare Zedek Medical Center
- RECRUITINGNCT06693531A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareRegeneron Pharmaceuticals
- RECRUITINGPHASE4NCT06665971Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)University of California, San Diego
See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis →